期刊文献+

蛋白质转导超氧物歧化酶融合蛋白在脑缺血/缺氧损伤中的研究进展 被引量:6

Progress of protein transducfion domain-superoxide dismutase fusion protein in cerebral ischemia/reperfusion injury
原文传递
导出
摘要 背景蛋白质转导超氧物歧化酶融合蛋白(proteintransductiondomain—superoxidedismuta8efusionDrotein.FFD-SOD)是采取基因工程的方法制备的一种新型融合蛋白,具备穿膜和抗自由基损伤的功能,是近年来研究的热点。目的增加对融合蛋白FFD-SOD的认识以及了解其在脑缺血,再灌注(ischemia/reperfusion,I/R)中的研究现状。内容蛋白质转导结构域(proteintransductiondomain,FrD)作为PTD-SOD的组成部分可以介导外源超氧化物歧化酶(superoxidedismutase.SOD)穿透生物膜,从融合蛋白PTD-SOD的结构、制备方法、活性检测以及其在脑I/R损伤中的应用等方面作一综合性描述。趋向该技术解决了SOD作为大分子蛋白质难以通过细胞膜的难题,在脑保护的研究中具有重要意义。 Background A new type of fusion protein--protein transduction domain-superoxide dismutase fusion protein (PTD-SOD) made by genetic engineering, is a research hotspot in recent years. Objective We will describe the concept of fusion protein PTD-SOD and review the progress of PTD-SOD in cerebral ischemia/reperfusion(I/R) injury. Content Protein transduction domain(PTD), as a part of PTD-SOD, can bring exogenous superoxide dismutase(SOD) into cells. We will introduce the structure, preparation methods, activity of fusion protein PTD-SOD and its application in cerebral I/R injury in this review. Trend SOD, a macromolecular protein, is very difficult to go through the cell membrane, but the development of PTD-SOD can perfectly solve this problem and provide a very important progress in brain protection study.
出处 《国际麻醉学与复苏杂志》 CAS 2014年第2期188-192,共5页 International Journal of Anesthesiology and Resuscitation
基金 国家自然科学基金(81071070)
关键词 蛋白质转导超氧物歧化酶融合蛋白 脑缺血 缺氧损伤 Protein transduction domain- superoxide dismutase fusion protein Cerebral ischemia and hypoxia injury
  • 相关文献

参考文献18

  • 1Perry J J, Shin DS, Getzoff ED, et al. The structural biochemistry of the superoxide dismutases[J]. Biochim Biophys Acta, 2010, 1804 (2) : 245 -262. 被引量:1
  • 2Yamakura F, Kawasaki H. Post-translational modifications of superoxide dismutase[J]. Biochim Biophys Acta, 2010, 1804(2): 318-325. 被引量:1
  • 3Abreu IA, Cabelli DE. Superoxide dismutases-a review of the metal-associated mechanistic variations[J]. Biochim Biophys Acta, 2010, 1804(2): 263-274. 被引量:1
  • 4Matsui H, Tomizawa K, Lu YF, et al. Protein therapy: in vivo protein transduction by polyarginine (llR) PTD and subcellular targeting delivery [J]. Curt Protein Pept Sci, 2003, 4 (2): 151-157. 被引量:1
  • 5Ho A, Schwarze SR, Mermelstein S J, et al. Synthetic protein transduction domains: enhanced transduetion potential in vitro and in vivo[J]. Cancer Res, 2001, 61(2): 474-477. 被引量:1
  • 6Yu D, Jin C, Ramaehandran M, et al. Adenovirus serotype 5 vectors with Tat-PTD modified hexon and serotype 35 fiber show greatly enhanced transduction capacity of primary cell cultures [J]. PLoS One, 2013, 8(1): e54952. 被引量:1
  • 7刘强,梁英民,郑瑾,邝芳,蒋姗姗,陈任安,吴绒丽.PTD介导蛋白通过血脑屏障及其在脑组织中的分布[J].中国现代医学杂志,2003,13(5):33-35. 被引量:6
  • 8Asoh S, Ohta S. PTD-mediated delivery of anti-cell death proteins/ peptides and therapeutic enzymes [J]. Adv Drug Deliv Rev, 2008, 60(4-5): 499-516. 被引量:1
  • 9Kwon HY, Eum WS, Jang HW, et al. Transduction of Cu, Zn- superoxide dismutase mediated by an HIV-ltat protein basic domaininto mammalian cells[J]. FEBS Lett, 2000, 485(2-3): 163-167. 被引量:1
  • 10Eum WS, Choung IS, Li MZ, et al. HIV-1 TAT-mediated protein transduction of Cu, Zn-superoxide dismutase into pancreatic cells in vitro and in vivo[J]. Free Radic Biol Med, 2004, 37(3): 339-349. 被引量:1

二级参考文献25

共引文献11

同被引文献48

引证文献6

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部